Terms: = Germ cell tumor AND MYC, c-Myc, 4609, ENSG00000136997 AND Prognosis
578 results:
1. Patient-derived tumoroid models of pulmonary large-cell neuroendocrine carcinoma: a promising tool for personalized medicine and developing novel therapeutic strategies.
Yokota E; Iwai M; Yukawa T; Naomoto Y; Haisa M; Monobe Y; Takigawa N; Fukazawa T; Yamatsuji T
Cancer Lett; 2024 Apr; 588():216816. PubMed ID: 38499265
[TBL] [Abstract] [Full Text] [Related]
2. UCHL1 is a potential molecular indicator and therapeutic target for neuroendocrine carcinomas.
Liu S; Chai T; Garcia-Marques F; Yin Q; Hsu EC; Shen M; Shaw Toland AM; Bermudez A; Hartono AB; Massey CF; Lee CS; Zheng L; Baron M; Denning CJ; Aslan M; Nguyen HM; Nolley R; Zoubeidi A; Das M; Kunder CA; Howitt BE; Soh HT; Weissman IL; Liss MA; Chin AI; Brooks JD; Corey E; Pitteri SJ; Huang J; Stoyanova T
Cell Rep Med; 2024 Feb; 5(2):101381. PubMed ID: 38244540
[TBL] [Abstract] [Full Text] [Related]
3. Histone demethylase KDM4B accelerates the progression of glioblastoma via the epigenetic regulation of myc stability.
Wang Z; Cai H; Li Z; Sun W; Zhao E; Cui H
Clin Epigenetics; 2023 Dec; 15(1):192. PubMed ID: 38093312
[TBL] [Abstract] [Full Text] [Related]
4. The promoting effect and mechanism of MAD2L2 on stemness maintenance and malignant progression in glioma.
Liu Z; Wang S; Yu K; Chen K; Zhao L; Zhang J; Dai K; Zhao P
J Transl Med; 2023 Nov; 21(1):863. PubMed ID: 38017538
[TBL] [Abstract] [Full Text] [Related]
5. Mitotic Dysregulation at tumor Initiation Creates a Therapeutic Vulnerability to Combination Anti-Mitotic and Pro-Apoptotic Agents for mycN-Driven Neuroblastoma.
Zhai L; Balachandran A; Larkin R; Seneviratne JA; Chung SA; Lalwani A; Tsubota S; Beck D; Kadomatsu K; Beckers A; Durink K; De Preter K; Speleman F; Haber M; Norris MD; Swarbrick A; Cheung BB; Marshall GM; Carter DR
Int J Mol Sci; 2023 Oct; 24(21):. PubMed ID: 37958555
[No Abstract] [Full Text] [Related]
6. POU2F3-Expressing Small cell Lung Carcinoma and Large cell Neuroendocrine Carcinoma Show Morphologic and Phenotypic Overlap.
Jimbo N; Ohbayashi C; Takeda M; Fujii T; Mitsui S; Tsukamoto R; Tanaka Y; Itoh T; Maniwa Y
Am J Surg Pathol; 2024 Jan; 48(1):4-15. PubMed ID: 37904277
[TBL] [Abstract] [Full Text] [Related]
7. Chelators as Antineuroblastomas Agents.
D'Acunto CW; Gbelcová H; Kaplánek R; Pospíšilová M; Havlík M; Ruml T
Physiol Res; 2023 Oct; 72(S3):S277-S286. PubMed ID: 37888971
[TBL] [Abstract] [Full Text] [Related]
8. Identification of tumor-intrinsic drivers of immune exclusion in acral melanoma.
Augustin RC; Newman S; Li A; Joy M; Lyons M; Pham MP; Lucas P; Smith K; Sander C; Isett B; Davar D; Najjar YG; Zarour HM; Kirkwood JM; Luke JJ; Bao R
J Immunother Cancer; 2023 Oct; 11(10):. PubMed ID: 37857525
[TBL] [Abstract] [Full Text] [Related]
9. Comparative Analysis of the Embryonal Brain tumors Based on Their Molecular Features.
Shcherbina V; Kovalevska L; Pedachenko E; Malysheva T; Kashuba E
Discov Med; 2023 Oct; 35(178):733-749. PubMed ID: 37811612
[TBL] [Abstract] [Full Text] [Related]
10. [Clinicopathological and prognostic features of subungual melanoma in situ].
Hu J; Ren M; Cai X; Lyu JJ; Shen XX; Kong YY
Zhonghua Bing Li Xue Za Zhi; 2023 Oct; 52(10):1006-1011. PubMed ID: 37805391
[No Abstract] [Full Text] [Related]
11. Cordycepin improves sensitivity to temozolomide in glioblastoma cells by down-regulating myc.
Zheng SX; Chen J; Zhuang BB; Zhang Q; Shi SS; Zhang GL
J Cancer Res Clin Oncol; 2023 Nov; 149(17):16055-16067. PubMed ID: 37695389
[TBL] [Abstract] [Full Text] [Related]
12. myc up-regulation confers vulnerability to dual inhibition of CDK12 and CDK13 in high-risk Group 3 medulloblastoma.
Pitolli C; Marini A; Guerra M; Pieraccioli M; Marabitti V; Palluzzi F; Giacò L; Tamburrini G; Cecconi F; Nazio F; Sette C; Pagliarini V
J Exp Clin Cancer Res; 2023 Aug; 42(1):214. PubMed ID: 37599362
[TBL] [Abstract] [Full Text] [Related]
13. EYA2 tyrosine phosphatase inhibition reduces myc and prevents medulloblastoma progression.
Wolin AR; Vincent MY; Hotz T; Purdy SC; Rosenbaum SR; Hughes CJ; Hsu JY; Oliphant MUJ; Armstrong B; Wessells V; Varella-Garcia M; Galbraith MD; Pierce A; Wang D; Venkataraman S; Danis E; Veo B; Serkova N; Espinosa JM; Gustafson DL; Vibhakar R; Ford HL
Neuro Oncol; 2023 Dec; 25(12):2287-2301. PubMed ID: 37486991
[TBL] [Abstract] [Full Text] [Related]
14. Optimizing reirradiation for relapsed medulloblastoma: identifying the ideal patient and tumor profiles.
Massimino M; Vennarini S; Buttarelli FR; Antonelli M; Colombo F; Minasi S; Pecori E; Ferroli P; Giussani C; Schiariti M; Schiavello E; Biassoni V; Erbetta A; Chiapparini L; Nigro O; Boschetti L; Gianno F; Miele E; Modena P; De Cecco L; Pollo B; Barretta F
J Neurooncol; 2023 Jul; 163(3):577-586. PubMed ID: 37326761
[TBL] [Abstract] [Full Text] [Related]
15. Neuroblastoma in uncommon age group - A case series diagnosed on cytology.
Dharmalingam P; Chenniappan AD; Alashetty S; Bidadi Lingappa K; Patil Okaly GV
Diagn Cytopathol; 2023 Oct; 51(10):629-635. PubMed ID: 37326472
[TBL] [Abstract] [Full Text] [Related]
16. The myc Family and the Metastasis Suppressor NDRG1: Targeting Key Molecular Interactions with Innovative Therapeutics.
Deng Z; Richardson DR
Pharmacol Rev; 2023 Sep; 75(5):1007-1035. PubMed ID: 37280098
[TBL] [Abstract] [Full Text] [Related]
17. NAA10 overexpression dictates distinct epigenetic, genetic, and clinicopathological characteristics in adult gliomas.
Le MK; Vuong HG; Nguyen TTT; Kondo T
J Neuropathol Exp Neurol; 2023 Jun; 82(7):650-658. PubMed ID: 37253389
[TBL] [Abstract] [Full Text] [Related]
18. The deubiquitinase USP28 maintains the expression of the transcription factor mycN and is essential in neuroblastoma cells.
Li J; Peng J; Wu L; Shen X; Zhen X; Zhang Y; Ma H; Xu Y; Xiong Q; Zhu Q; Zhang P
J Biol Chem; 2023 Jul; 299(7):104856. PubMed ID: 37230388
[TBL] [Abstract] [Full Text] [Related]
19. Identification of BRAF, CCND1, and myc mutations in a patient with multiple primary malignant tumors: a case report and review of the literature.
Liu Z; Jin C; Zhang Y; Jiang Y; Wang J; Zheng L
World J Surg Oncol; 2023 May; 21(1):158. PubMed ID: 37221610
[TBL] [Abstract] [Full Text] [Related]
20. Neuroblastoma-derived v-myc avian myelocytomatosis viral related oncogene or
Bhardwaj N; Das G; Srinivasan R
J Clin Pathol; 2023 Aug; 76(8):518-523. PubMed ID: 37221048
[TBL] [Abstract] [Full Text] [Related]
[Next]